Study of Multisensory Early Oral Human Milk M-MILK for Very Preterm Infants Born Before 32 Weeks to Improve Stress, Brain Development, and Feeding Skills
Led by Loyola University · Updated on 2026-01-20
125
Participants Needed
2
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to find out if the multisensory early oral administration of human milk M-MILK helps very preterm infants born before 32 weeks gestational age. The study will evaluate whether M-MILK can improve stress regulation, support healthy brain development, and enhance oral feeding skills compared to standard care. Researchers will measure factors like cortisol levels, DNA changes in stress-related genes, neurodevelopment, and feeding abilities in these infants.
Participants will be randomly assigned to one of two groups. Infants in the M-MILK group will receive the M-MILK intervention and standard care starting on day 3 of life during the day shift, up to four times daily. M-MILK is given in small amounts via a syringe, using either mothers milk or donor milk, based on availability, and continues until the infant begins oral feeding. The control group will receive standard care without M-MILK.
During the study, infants will be monitored for oral feeding skills using the Early Feeding Skills EFS assessment up to 12 weeks after birth and again at 36 weeks postmenstrual age. Researchers will also measure stress regulation through salivary cortisol and DNA methylation tests, and assess neurodevelopment with detailed neurological and behavioral scores at 36 weeks postmenstrual age. This comprehensive follow-up aims to capture the effects of M-MILK on early development and feeding in very preterm infants.
CONDITIONS
Brief Title
Multisensory Early Oral Administration of Human Milk (M-MILK) for Very Preterm Infants
Research Team
T
Thao Griffith, PhD
C
Cara Joyce, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor
How This Trial Compares With Other Options
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
M‑MILK (investigational)
Standard care (trial control)
Routine oral feeding support (external context)
What it is
An infant‑led intervention starting on day 3 of life in which very preterm infants receive small droplets of human milk via syringe with multisensory engagement (M‑MILK)
Standard neonatal feeding care without added multisensory milk droplets
Routine oral feeding support guided by current feeding protocols for very preterm infants
Role in trial
Test the effect of adding multisensory oral milk droplets to feeding care
Serves as the comparator arm receiving usual feeding care
Represents standard feeding support procedures outside trial context
Primary use
To enhance stress regulation, neurodevelopment, and oral feeding skills in very preterm infants
To provide baseline feeding support without multisensory intervention
Neonatal feeding protocols aim to support safe transition to oral feeding
How it is given or performed
Small droplets (up to 1 mL) of human milk delivered via syringe with multisensory context after hands‑on care up to four times daily
Usual care without added milk droplets
Feeding protocols typically include caregiver‑led feeding support based on developmental readiness
Evidence status
Efficacy not yet established; trial is ongoing to evaluate impact on oral feeding and neurodevelopment
Evidence for feeding support as standard care based on clinical consensus
Systematic reviews show oral motor and sensory interventions improve feeding outcomes compared with routine care
Important risks
Safety profile not yet characterized; potential risks have not been reported
Standard care feeding support generally well tolerated
Routine feeding support interventions generally safe within NICU settings
Important limitations
Efficacy and safety are unknown until trial results are available
Control arm lacks multisensory enhancement; may not reflect optimized feeding support
Routine care varies between centers and lacks multisensory component
Patient impact
Impact on feeding skills, stress regulation, and development not yet known
Provides baseline feeding support; typical progress expected per standard care
Evidence shows oral motor interventions can shorten time to full oral feeding and readiness
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 23Weeks - 32Weeks
All Genders
Eligibility Criteria
You may qualify if you...
Born at or before 32 weeks gestational age.
Receiving mother's own milk and/or donor human milk at the time of screening.
You will not qualify if you...
Receiving only formula feeding.
Having gastrointestinal defects such as cleft lip or cleft palate.
Having congenital cardiac defects that require surgery.
Diagnosed with necrotizing enterocolitis.
Having chromosomal abnormalities.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - From day 3 of life until oral feeding initiation
Participants in the M-MILK group receive multisensory early oral administration of human milk starting on day 3 of life, given during the day shift after hands-on care and up to 4 times a day. This continues until oral feeding initiation. Participants in the control group receive standard of care.
Daily visits during treatment period
Follow-up
Duration - Up to 12 weeks after birth to 36 weeks postmenstrual age
Participants are assessed for oral feeding skills, stress regulation, and neurodevelopmental outcomes up to 36 weeks postmenstrual age.
Approximately 2 visits up to 36 weeks postmenstrual age
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Finding the Lowest Effective Dose of Dobutamine to Treat Low Blood Flow in Very Preterm Infants During Their First 72 Hours
Using Forced Oscillometry to Measure Lung Function
in Infants With Bronchopulmonary Dysplasia and Healthy Term Infants
Study of Early Interaction and Cognitive Training Using Finger Puppets and Bookworm Reading for Preterm Infants Born Before 34 Weeks
Study of Multisensory Early Oral Human Milk M-MILK for Very Preterm Infants Born Before 32 Weeks to Improve Stress, Brain Development, and Feeding Skills
Study Comparing Repetitive and Selective Touch Stimulation for Infants Born Before 32 Weeks to Improve Oxygen Levels After Birth
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Study Protocol for a Randomized Controlled Trial of Multisensory Early Oral Administration of Human Milk (M-MILK) for Very Preterm Infants: Enhancing Stress Regulation, Neurodevelopment, and Oral Feeding Skills.
Thao Griffith, Linda Janusek, Rosemary White-Traut...